Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease

Details for Australian Patent Application No. 2005251816 (hide)

Owner Kalypsys, Inc.

Inventors Wiley, Brandon; Lawrence, Charles; Malecha, James; Noble, Stewart; Hassig, Christian; Hoffman, Timothy; Wash, Paul

Agent EF WELLINGTON & CO

Pub. Number AU-A-2005251816

PCT Pub. Number WO2005/120515

Priority 10/865,743 10.06.04 US; 60/635,019 09.12.04 US; PCT/ US2004/018502 10.06.04 US

Filing date 9 June 2005

Wipo publication date 22 December 2005

International Classifications

C07C 327/30 (2006.01) Thiocarboxylic acids

C07C 329/06 (2006.01) Thiocarbonic acids

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/70 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/76 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 231/18 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 239/40 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 251/22 (2006.01) Heterocyclic compounds containing 1,3,5-triazine rings

C07D 261/10 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 263/50 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 271/07 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 307/64 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/34 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/36 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07F 9/165 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/120515 Priority application(s): WO2005/120515

18 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251818-Vaccine compositions and methods

2005251814-Local delivery of growth factors for stem cell transplantation